TTR and amyloidosis: Recently, novel RNA‐targeted therapies have demonstrated effectiveness in treating PNP associated with amyloidosis, notably ATTRv amyloidosis, by curtailing abnormal protein formation and stabilizing the normal tetrameric structure of transthyretin [15, 17, 19, 20, 23].